ViaLogy Acquiring MDx Firm Premaitha Health for $17.8M; Plans to Launch NIPT in 2015 | GenomeWeb

NEW YORK (GenomeWeb) – Investment firm ViaLogy today announced it is acquiring UK molecular diagnostics firm Premaitha Health for £10.5 million ($17.8 million) in a reverse takeover.

ViaLogy will take on the Premaitha Health name with its shares to begin trading on the London Stock Exchange's AIM market next month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.